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Meat industry generates large volumes of by-products like blood, bones, meat 23 
trimmings, skin, fatty tissues, horns, hoofs, feet, skull and viscera among others that are 24 
costly to be treated and disposed ecologically. These costs can be balanced through 25 
innovation to generate added value products that increase its profitability. Rendering 26 
results in feed ingredients for livestock, poultry and aquaculture as well as for pet foods. 27 
Energy valorisation can be obtained through the thermochemical processing of meat and 28 
bone meal or the use of waste animal fats for the production of biodiesel. More recently, 29 
new applications have been reported like the production of polyhydroyalkanoates as 30 
alternative to plastics produced from petroleum. Other interesting valorisation strategies 31 
are based on the hydrolysis of by-products to obtain added value products like bioactive 32 
peptides with relevant physiological effects as antihypertensive, antioxidant, 33 
antidiabetic, antimicrobial, etc. with promising applications in the food, pharmaceutical 34 
and cosmetics industry. This paper reports and discusses the latest developments and 35 
trends in the use and valorisation of meat industry by-products. 36 
 37 
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1. Introduction 40 
Meat industry generates large volumes of by-products like blood, bones, meat 41 
trimmings, skin, fatty tissues, horns, hoofs, feet, skull and viscera among others that are 42 
costly to be treated and disposed ecologically (Ryder, Ha, El-Din Bekhit and Carne, 43 
2015). These costs can be balanced through innovation to generate added value products 44 
that increase its profitability. On the other hand, unappropriated treatment or handling 45 
of such by-products raised relevant crisis in the past such as the spread of the 46 
spongiform encephalopathies. The European Commission published the Regulation 47 
(EC) 1069/2009 laying down health rules as regards animal by-products and derived 48 
products not intended for human consumption and repealing Regulation (EC) 49 
1774/2002. Later, the European Commission published the Regulation (EC) 142/2011 50 
that was implementing the Regulation 1069/2009. Rules were also provided by the Food 51 
and Drug Administration (FDA, 2004) to prevent the establishment and spread of 52 
bovine spongiform encephalopathy (BSE) in the United States, including a prohibition 53 
on the use of high-risk, cattle-derived materials that can carry the BSE agent which are 54 
defined as specified risk material. This means that adequate disposal of by-products 55 
may increase the cost to processors and makes necessary to produce new substances or 56 
products capable to cover the disposal costs (Toldrá, Mora, Aristoy and Reig, 2012). 57 
It must be taken into account that certain meat by-products can be considered as foods 58 
of interest depending on the country and local traditions while in other places they can 59 
be considered as inedible foods (Ockerman & Basu, 2004a). In fact, some by-products 60 
with high nutritional value like blood, liver, lung, heart, kidney, brains, spleen and tripe 61 
constitute part of the diet and culinary recipes in many countries worldwide (Nollet & 62 
Toldrá, 2011). Of course, the nutritional composition depends on each particular type of 63 
by-product and the animal species from which they are obtained (Honikel, 2011). Other 64 
by-products like lard may be used for cooking. 65 
Meat by-products may constitute a valuable resource if handled properly to produce 66 
added value substances or products (Zhang, Xiao, Samaraweera, Lee & Ahn, 2010, 67 
Toldrá and Reig, 2011). Efficient use of by-products may arise up to 11.4% and 7.5% of 68 
the gross income of beef and pork (Jayathilakan, Sultana and Radhakrishna, 2012). 69 
There is a large variety of meat by-products but, in general, most of them contain good 70 
amounts of nutrients like essential amino acids, minerals and vitamins (Aristoy & 71 
Toldrá, 2011, Honikel, 2011, Kim, 2011), constituting good valorization opportunity for 72 
the meat industry (Valta, Damala, Orli, Papadaskalopoulou, Moustakas, Malamis and 73 
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Loizidou, 2015). There are numerous applications based on new or improved 74 
technologies for processing meat by-products like edible food ingredients for the food, 75 
feed and pet food industry (see Figure1). Meat by-products can be considered as raw 76 
materials for the generation of biomolecules of interest like protein hydrolysates with 77 
relevant bioactivities or enzymes (Lasekan, Abu Bakar and Hashim, 2013), extracts 78 
with functional properties (Chernukha, Fedulova and Kotenkova, 2015) or bioactive 79 
peptides (Mora, Reig and Toldrá, 2014; Martínez-Alvarez, Chamorro and Brenes, 80 
2015). 81 
Other applications are addressed towards inedible products like fertilizers, substances of 82 
interest for the chemical or pharmaceutical industry or energy generation (see Figure 1).  83 
Energy generation is an active area mainly focused on the biodiesel production from 84 
waste animal fats (Banckovic-Illic, Stojkovic, Stamenkovic and Veljkovic, 2014; 85 
Adewale, Dumont and Ngadi, 2016) or even a second generation of bioderived diesel 86 
fuel, also known as bio gas oil (Balandincz and Hancsók, 2015). 87 
This manuscript reports and discusses the latest developments and trends in the use and 88 
valorisation of meat industry by-products. 89 
 90 
2. Food applications 91 
 92 
Applications as functional ingredients 93 
Bioactive peptides are sequences usually between 2 and 20 amino acids that exert a 94 
biological function in one or several of the physiological systems in human being. In 95 
this sense, hypocholesterolemic, antioxidant and antithrombotic peptides have been 96 
described to modulate the cardiovascular system whereas mineral binding and 97 
immunomodulatory peptides act in gastrointestinal and immune systems, respectively. 98 
Some groups of peptides are able to participate in multiple system reactions. Thus, 99 
opioid agonist and antagonists can act on nervous, gastrointestinal, and immune 100 
systems, whereas antimicrobial peptides can modulate gastrointestinal and immune 101 
systems (Lafarga and Hayes, 2014). 102 
Bioactive peptides need to be liberated from their origin protein in order to exert the 103 
biological function as they are inactive within the parent protein (Vercruisse, Van 104 
Camp, and Smagghe, 2005). Some bioactive peptides are released during food 105 
processing either in fermentation or curing stages, whereas others are generated during 106 
gastrointestinal digestion. The main problem of naturally generated peptides is the 107 
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difficulty in controlling the hydrolysis conditions because many endogenous enzymes 108 
are acting at the same time and a wide profile of peptides showing different sizes and 109 
characteristics is generated (Mora, Gallego, Escudero, Reig, Aristoy & Toldrá, 2015). 110 
For this reason, the digestion of protein extracts under controlled hydrolysis conditions 111 
using known enzymes such as alcalase, pepsin, thermolysine, trypsin, etc., allows the 112 
control of the generated bioactive peptides as well as the obtention of more 113 
homogeneous batches. 114 
The use of by-products as a source of bioactive peptides has been extensively studied 115 
during the last years. In this sense, blood and collagen, very important by-products from 116 
slaughterhouses and meat industry, have been the most assayed (Ryder, El-Din Bekhit, 117 
McConnell and Carne, 2016). 118 
Blood is a rich source of proteins where hemoglobin, an iron-containing protein, is the 119 
most abundant complex (Ofori and Hsieh, 2014). It is obtained all around the world and 120 
even though is used as food ingredient in Europe, Asia, and Africa, its production is 121 
more copious than needed. Its value as a source of bioactive peptides has been studied 122 
in both the cellular fraction (hemoglobin cells) and the plasma fraction, and their 123 
hydrolysates have been described to exert antimicrobial, antioxidant, ACE-inhibitory, 124 
and opioid activities (Chang, Wu and Chiang, 2007). However, antimicrobial peptides 125 
derived from hemoglobin hydrolysates have been the most studied (Nedjar-Arroume et 126 
al., 2004; Marya, Kouach, Briand and Guillochon, 2005; Briand and Guillochon, 2006, 127 
2008). Bovine hemoglobin hydrolysate obtained with pepsin in the presence of 30% 128 
ethanol resulted in the novel identification of 67-106, 73-105, 99-105, and 100-105 129 
fragments of the α-chain of bovine hemoglobin. These peptides exert an antibacterial 130 
activity against Kocuria luteus A270, Listeria innocua, Escherichia coli, and 131 
Staphylococcus aureus with a MIC between 187.1 and 35.2 µM as well as an ACE 132 
inhibitory activity with IC50 values from 42.55 to 1,095 µM (Adje et al 2011a). On the 133 
other hand, Hu et al. (2011) identified the peptide VNFKLLSHSLLVTLASHL from α-134 
chain bovine hemoglobin showing antimicrobial activity against E. coli, S. aureus, and 135 
Candida albicans when assessed. The minimal peptide sequences necessary to show 136 
antimicrobial activity after a pepsin enzyme digestion of α- and β-chain hemoglobin 137 
proteins have been described to be KYR and RYH, respectively, and were studied 138 
against E. coli, Salmonella enteritidis, L. innocua, Micrococcus luteus, and S. aureus 139 
(Catiau et al 2011a, 2011b). The sequences obtained from blood protein hydrolysates in 140 
recent years are shown as Table 1. 141 
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The generation of bioactive peptides depends to a high extent on the enzymes and 142 
substrate used in the hydrolysis.  In fact, the hydrolysis degree determines the extent of 143 
hydrolysis whereas the digestion conditions (temperature, pH, and time) are very 144 
important to obtain the bioactive peptides. On the other hand, peptide size and amino 145 
acid sequences are crucial for the bioactive potential of the peptides (Yu, Hu, 146 
Miyaguchi, Bai, Du and Lin, 2006). As an example, antimicrobial peptides have been 147 
shown to be mostly hydrophobic as higher hydrophobicity is necessary in the affinity 148 
with the outer membrane of microbials. In fact, there is an interaction with negatively 149 
charged membrane phospholipids by tyrosine residues together with arginine and lysine 150 
which can act as peptide anchors in membranes (Lopes, Fedorov and Castanho, 2005). 151 
ACE-inhibitory peptides, also well-studied in hemoglobin hydrolysates, have been 152 
described to contain proline, lysine or aromatic residues. In fact, ACE binding is 153 
influenced by a proline residue at any of the three last positions of the C-terminal site. 154 
Antimicrobial and ACE-inhibitory peptides derived from bovine and porcine 155 
hemoglobin and plasma have been described in Table 1. Some opioid peptides with 156 
potential to have an effect on nervous and gastrointestinal systems have also been 157 
described from animal blood sources (Zhao et al., 1997, 1994; Kapel et al., 2003; 158 
Froidevaux et al., 2008). However, there is a lack of studies about the antioxidant 159 
capability of hemoglobin-derived peptides. 160 
Collagen is the most abundant protein in many by-products obtained from meat 161 
industry. In fact, it is the main constituent in skin, hide, bones, and cartilages. The 162 
nutritional value of collagen is very low because it lacks essential amino acids but, on 163 
the other hand, collagen is very useful as a source of bioactive peptides (Morimatsu, 164 
2008, Dierckx and Smagghe, 2011). Despite many recent studies have been focused on 165 
the bioactive properties of collagen hydrolysates, most of the published studies have 166 
been focused on fisheries by-products. In collagen hydrolysates, ACE-inhibitory and 167 
antioxidant activities resulted to be the most relevant when enzymes such as alcalase, 168 
trypsin, chymotrypsin, neutrase, flavorenzyme, pepsin, bromelain and papain were used 169 
(Saiga et al., 2008; Gómez-Guillén et al. 2011; Di Bernardini, Mullen, Bolton, Kerry, 170 
O'Neill & Hayes, 2012). In this sense, Herregods et al (2011) reported that thermolysin 171 
hydrolysate showed the highest in vitro ACE inhibitory activity as well as an important 172 
in vivo antihypertensive effect in spontaneously hypertensive rats. Recently, a MALDI-173 
ToF mass spectrometry methodology has been used to determine the animal origin from 174 
collagen trypsinated peptides in food preparations and galenic formulations. The 175 
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differentiation between pork and bovine gelatin was performed through the mass spectra 176 
(Flaudrops et al., 2015). 177 
 178 
Technological applications 179 
The cellular fraction that contains red blood cells, white blood cells and platelets, can be 180 
used as colour enhancer for sausages even though it has limited applications in foods 181 
due to the dark colour of hemoglobin, sensory adverse effects or even hygiene (Ofori & 182 
Hsieh, 2011). Better flavor can be obtained if hemoglobin is removed and used to 183 
replace fat in meat products (Viana, Silva, Delvivo, Bizzotto & Silvestre, 2005).  184 
A heme iron polypeptide that helps for a better iron absorption can be generated through 185 
enzymatic hydrolysis of hemoglobin (Nissenson, Berns, Sakiewickz, Ghaddar, Moore & 186 
Schleicher, 2003).  187 
Interesting technological properties for food processing can be obtained from blood 188 
proteins (Hsieh and Ofori, 2011). So, immunoglobulins, fibrinogen and serum albumin 189 
contribute to gelation and emulsification (Cofrades, Guerra, Carballo, Fernández-Martín 190 
& Jiménez-Colmenero, 2000) while other plasma proteins contribute to proteins cross-191 
linking (Kang & Lanier, 1999), proteins enrichment (Yousif, Cranston and Deeth, 2003) 192 
or foaming (Del, Rendueles and Díaz, 2008). High antioxidant activity has been 193 
reported in red blood cell fractions from sheep, pig, cattle and red deer (Bah, Bekhit, 194 
Carne and McConnell, 2016). Also, antimicrobial activity against E. coli, S. aureus and 195 
P. aeruginosa was reported in sheep white blood cells (Bah et al., 2016). 196 
 The enzyme thrombin and fibrinogen are used for binding of meat pieces and, for 197 
instance, reconstitute meat steaks or generate meat emulsions increasing the hardness 198 
and springiness. Fibrinogen is converted by thrombin into insoluble fibrin that form 199 
fibers by aggregation. The final results is a three-dimensional network fibrin clot 200 
(Lennon, McDonald, Moon, Ward & Kenny, 2010) with more or less strength 201 
depending on the size and moisture of the pieces and the conditions of pH and 202 
temperature used (Chen & Lin, 2002). Thrombin and fibrinogen are registered under the 203 
trade mark Fibrimex® and commercialised as a binder for meat processing to 204 
manufacture restructured meat products.  205 
Gelatin is obtained from collagen through hydrolysis and is widely used in the food 206 
industry because of its good gel-forming ability, but also as clarifying agent, stabiliser 207 
or protective coating material (Djagny, Wang & Xu, 2001; Gómez-Guillen et al., 2011). 208 
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Animal rendering yields proteins that can reduce the surface tension and produce foams 209 
(Bressler, 2009). Protein hydrolysates are also used as flavor ingredients; their sensory 210 
properties depending on the balance and content of small peptides and free amino acids 211 
(Maehashi, Matsuzaki, Yamamoto & Udaka, 1999). 212 
 213 
3. Feed and pet food applications 214 
Raw or rendered animal by-products have been traditionally used as ingredients in feeds 215 
and pet foods. About 25 million tonnes per year of animal by-products derived from 216 
meat industries in the US and 15 million tonnes in the European Union are processed by 217 
rendering to produce high quality fats and proteins (Hamilton, 2016). In fact, animal by-218 
products constitute a good source of nutrients like essential amino acids, fatty acids, 219 
minerals and trace elements, B vitamins and some fat-soluble vitamins (Nollet and 220 
Toldrá, 2011; Honikel, 2011). Examples are protein or blood meals (Alexis & Robert, 221 
2004; Pérez-Gálvez, Almécija, Espejo, Guadix and Guadix, 2011), amino acids 222 
solutions obtained from blood (Giu & Giu, 2010) or meat and bone meal ashes obtained 223 
after co-incineration (Goutand, Cyr, Deydier, Guilet and Clastres, 2008). Meat and bone 224 
meal is also a good source of essential amino acids and group B vitamins for animal 225 
feeds (Jayathilakan et al., 2012). Protein hydrolysates have been reported to be 226 
successful in aquaculture (Gilbert, Wong and Webb, 2012). Excessive bitterness in 227 
protein hydrolysates can be reduced by cleaving hydrophobic amino acids from peptides 228 
and make the palatability more appealable in pet foods (Nchienzia, Morawicki and 229 
Gadang, 2010).Rendered meat by-products are also used as ingredients for dogs pet 230 
foods (Murray, Patil, Fahey, Merchen and Hughes, 1997).  231 
Meat by-products protein hydrolysates represent an interesting alternative to soybean 232 
meal because the absence of antinutritional factors or allergenic proteins and the 233 
presence of large amounts of all essential amino acids (Martínez-Alvarez, Chamorro 234 
and Brenes, 2015). Other by-products like hair, nail, feather and outer layer of skin 235 
containing keratin, can be profitable after hydrolysis with the enzyme keratinase 236 
(Deivasigamani & Alagappan, 2008; Lasekan, Abu Bakar and Hashim, 2015). This 237 
enzyme is predominantly a serine peptidase with a broad range of neutral-alkaline pH 238 
for activity, pH ranging 6.0-13.0, and able to hydrolyse keratin under reducing 239 
conditions (Brandelli, Sala and Kalil, 2015). 240 
 241 
4. Energy generation applications 242 
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In recent years, biodiesel has been produced and is now replacing progressively the 243 
diesel fuel due to its advantages like being biodegradable, non-toxic and with a 244 
favorable combustion emission profile that leads to reductions in carbon dioxide, carbon 245 
monoxide, particulate matter and unburned hydrocarbons (Gerpen, 2005; Moreira, Dias, 246 
Almeida & Alvim-Ferraz, 2010). Further, the use of biodiesel does not imply significant 247 
modifications in engines.  248 
Low cost animal fat by-products are used as raw materials that are transesterified with a 249 
low molecular weight alcohol to yield a mixture of fatty acid methyl esters and glycerol 250 
as a side product (Bhatti, Hanif, Qasim & Rheman, 2008; Moreira et al., 2010). Hydro-251 
oxygenation and hydroisomerization in tubular reactors has been proposed to increase 252 
biodiesel profitability (Herskowitz, 2008), also supercritical transesterification 253 
(Marulanda, Anitescu & Tavlarides, 2010). Other recent studies focus on the improved 254 
production of biodiesel by using ultrasounds assisted transesterification of the animal 255 
fats (Adewale et al., 2016). Animal fats have some limitations due to its protein and 256 
phosphoacylglycerols content that makes a degumming process necessary, the presence 257 
of water that requires of vacuum drying and the high content of saturated fatty acids that 258 
need to be reduced through winterization process or additives addition (Banckovic-Illic 259 
et al., 2014). 260 
The developments have continued and nowadays a new 2nd generation, so-called bio gas 261 
oil is facing prompt application. Triacylglycerols are converted into a mixture of iso and 262 
normal paraffin via heterogeneous catalytic hydrogenation. Raw materials like brown 263 
greases have been also assayed with positive results (Baladincz and Hancsók, 2015). 264 
 265 
5. Medical and pharmaceutical applications 266 
Pork skin can be used as dressing for burns or skin ulcers in humans (Jayathilakan et al., 267 
2012). Glands and organs constitute edible meat by-products with good nutritive value 268 
that are consumed in different regions of the world (Nollet and Toldrá, 2011) and, in 269 
fact, some of them are consumed for medicinal purposes in countries like China, Japan 270 
and India, or used as a source of particular pharmaceutical substances. This is the case 271 
of bile from the gall bladder, melatonin from the pineal gland, heparin from the liver, 272 
progesterone and oestrogen from ovaries, insulin from pancreas, etc. (Jayathilakan et al., 273 
2012). Protein hydrolysates, especially those from collagen can generate peptides to be 274 
used in treatments against osteoarthritis by accumulation in the joint cartilage (Bello 275 
and Oeser, 2006). Hydrolysed collagen exerts a positive effect on bones and joints. In 276 
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fact, these hydrolysates with added hyaluronic acid are being commercialised for better 277 
performance of joints and pain relief in humans. 278 
Low molecular weight ultrafiltrates (<30kDa) obtained from pig aorta extracts were 279 
assayed with laboratory guinea pigs and such extracts were reported to exert substantial 280 
reductions in atherogenic lipoproteins, atherogenic index and total and residual 281 
cholesterol (Chernukha, Fedulova and Kotenkova, 2015). 282 
 283 
6. Fertilizer applications 284 
Large amounts of meat and bone meal are generated in all countries and an interesting 285 
approach is the thermochemical processing including pyrolysis, combustion and 286 
gasification. The most analysed are co-combustion with coal and pyrolysis. The 287 
resulting ashes demonstrate a high content of phosphorus which makes them suitable as 288 
fertilisers and the gas emissions are within the international regulations and contains 289 
combustibles to be used for energy production (Coutand, Cyr, Deydier, Guilet and 290 
Clastres, 2008; Cascarosa, Gea and Arauzo, 2012). The incineration of animal by-291 
products results in good mineral fertilisers. In addition, the use of heat recovery allows 292 
for efficient energy recovery (Nujak, 2015). 293 
 294 
7. Chemical applications 295 
Rendered fats have many applications in cosmetic industry for products like hand and 296 
body lotions, creams and bath products. Fatty acids are used in the chemical industry for 297 
rubber and plastic polymerization, softeners, lubricants and plasticizers (Ockerman and 298 
Basu, 2006). Collagen, gelatin and glycerin are also used in chemical industry as 299 
ingredients for surfactants, paints, varnishes, adhesives, antifreeze, cleaners and polishes 300 
(Pearl, 2004). New applications using rendered fats have been reported like the 301 
production of polyhydroyalkanoates with a recombinant strain of Ralstonia eutropha 302 
(Riedel, Jahns, Koenig, Bock, Brigham, Bader and Stahl, 2015). Such polymer has the 303 
advantage being biodegradable and constitutes an attractive alternative to plastics 304 
produced from petroleum. 305 
There are many applications for hides that traditionally have been used for leather-based 306 
articles like clothes, shoes, belts, handbags and purses (Ockerman & Basu, 2004b).  307 
 308 
8. Conclusions 309 
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There are many applications of meat by-products like feed ingredients for livestock, 310 
poultry and aquaculture as well as for pet foods, energy valorisation through biodiesel 311 
production, new substances as alternative to plastics and protein hydrolysates to be used 312 
for technological purposes or as a source of bioactive peptides with relevant 313 
physiological effects. Research efforts are going ahead to produce new substances with 314 
new applications or improving those existing processes. So, the innovation is 315 
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Legends for the figures 593 
 594 
Figure 1.- Flow diagram of main routes of applications for meat by-products  595 
 596 
 597 
